Compare ImmunityBio Inc. Common Stock (IBRX) vs RingCentral Inc. Class A Common Stock (RNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs RingCentral Inc. Class A Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while RingCentral Inc. Class A Common Stock trades at $78.59 (market cap $6.39B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and RingCentral Inc. Class A Common Stock pays a 0.36% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and RingCentral Inc. Class A Common Stock for 0 Days on average.
| IBRX | RNG | |
|---|---|---|
Market Cap | $10.33B | $6.39B |
Volume | 11,745,198 | 1,087,767 |
Sector | Health | Technology |
52-Week High | $11.55 | $79.82 |
52-Week Low | $1.98 | $24.82 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $7.44B |
Dividend Yield | — | 0.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About RingCentral Inc. Class A Common Stock
RingCentral provides cloud-based business communications and contact center solutions. Its platform combines phone, messaging, video meetings, and customer-service tools.
Read more on RNG →
